Clinical trial · Observational
Analysis of Expression of Specific Markers and Their Prognostic Significance in Hepatocellular Carcinoma
Analysis of the Incidence of Expression of Tumor Antigens and Tumor Marker in Cancer Tissue From Asian Patients With Hepatocellular Carcinoma and Evaluation of Prognostic Significance of These Tumor Antigens.
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Hepatocellular carcinoma is an aggressive disease with limited therapeutic options. Therefore, new approaches to treat this type of cancer are needed with immunotherapy potentially being one of these. As a first step in the development of novel therapies, expression analysis of specific markers, including tumor antigens will be carried out, and the correlation of expression with disease variables and clinical outcome will be assessed. This will be done retrospectively using archived hepatocellular carcinoma tissue samples.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hepatocellular Carcinoma | Hepatocellular Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Retrospective analysis of already archived samples | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Group A
- interventionNames
- Other: Retrospective analysis of already archived samples
Primary outcomes (3)
- measure
- The proportion of hepatocellular carcinoma patients whose tumor tissue expresses specific tumor antigens.
- timeFrame
- At the time of analysis
- measure
- The prognostic character of the expression of the tumor antigens
- timeFrame
- At the time of analysis
- measure
- Expression of c-MET in the same hepatocellular carcinoma tumor samples
- timeFrame
- At the time of analysis
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * The patient has pathologically proven hepatocellular carcinoma (any stage) * All the data required are available from patient's records Exclusion Criteria: N/A
References
Publications (0)
Data not yet available